Methods and compositions in breast cancer diagnosis and therapeutics
US7429650B2 · kind B2 · utility
5Cited by
2References
10Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 13, 2003 |
| Grant date | Sep 30, 2008 |
| Priority date | — |
| Expiry date | May 19, 2024 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2500/00
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
The present invention is directed to compositions regarding a specific mutation in estrogen receptor alpha and their use as diagnostic markers in breast tissue, such as premalignant lesions, for the development of breast cancer. More specifically, cells of breast cancer whose nucleic acid comprises the estrogen receptor alpha mutation identify the breast cancer to be an invasive breast cancer.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.